Docetaxel enhances the expression of E-cadherin and carcinoembryonic antigen (CEA) on human colon cancer cell lines in vitro

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 7-12

  Eckert, K ^a   Fuhrmann Selter, T ^a   Maurer, H R ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

CEA; Colon carcinoma cells; Docetaxel; E cadherin

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DOCETAXEL; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CADHERINS; CARCINOEMBRYONIC ANTIGEN; CELL DIVISION; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PACLITAXEL; TAXOIDS; TUMOR CELLS, CULTURED;

EID: 0031051154     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Horwitz SB: Mechanism of action of taxol. Trends Pharmacol Sci 13: 134-136, 1942.
2. Bissery MC, Guenard D, Gueritte-Vogelein F: Lavelle F: Experimental antitumor activity of taxotere (RP 56976. NSC 628506), a taxol analogue. Cancer Res 51: 4845-485, 1991.
3. Hanauske AR, Degen D, Hilsenbeck SG, Bissery MC, Von Hoff DD: Effects of taxotere and taxol on the in vitro colony formation of freshly explanted human tumor cells. Anti-Cancer Drugs 3: 121-124, 1992.
4. Ringel I, Horwitz SB: Studies with RP 56976 (Taxotere). a new semisynthetic analogue of taxol. J Nat Cancer Inst 83: 288-291, 1991.
5. Maurer HR, Eckert K, Bissery MC: Taxotere inhibits the proliferation and induces cell differentiation of HL-60 and K562 human myeloid leukemia cells in vitro. Int J of Oncol 3: 161-165, 1993.
6. Kanrantanis E, Nicholson S, Morris DL: Taxotere inhibits in vitro growth of human colonic cancer cell lines. Eur J Surg Oncol 20: 653- 657, 1994.
7. Manthey CL, Brandes ME, Perera PY, Vogel SN: Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein tyrosine phosphorylation in murine macrophages. J Immunol 149: 2459-2465, 1992.
8. Carboni JM, Sengh C, Tepper MA: Taxol and LPS activate a murine macrophage cell line and induce similar tyrosine phosphoproteins. J Natl Cancer Inst Monogr 15: 95-101, 1993.
9. Colin M, Guenard D, Gueritte-Voegelein F, Porlier P: US-Patent 4924012, granted May 8, 1990.
10. Rousset M: The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochemie 68: 1035-1040, 1986.
11. Toribara NW, Sack TL, Gum JR, Ho SB, Shively JE, Willson KV, Kim YS: Heterogeneity in the induction and expression of carcinoembryonic antigen-related antigens in human colon cancer cell lines. Cancer Res 49: 3321-3327, 1989.
12. Chakrabarty S, Tobon A, Varani J, Brattain MG: Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming grows factor-β. Cancer Res 48: 4059-4064, 1988.
13. Dorudi S, Sheffield JP, Poulsom R: E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 142: 981-986, 1993.
14. Behrens J, Mareel MM, van Ray FM, Birchmeier W: Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108: 2435-2447, 1989.
15. Kinsella AR, Lepts GC, Hill CL, Jones M: Reduced E-cadherin expression correlates with increased invasiveness in colorectal cell lines. Clin Exp Metastasis 12: 335-342, 1994.
16. Brattain MG, Levine AE, Chakrabarty S, Yeoman LC, Willson JKV, Long BH: Heterogeneity of human colon carcinoma. Cancer Met Rev 3: 177-191, 1984.
17. Wiggers T, Arends JW, Verstijnen C, Moerkerk PM, Bosman FT: Prognostic significance of CEA immunreactivity patterns in large bowel carcinoma tissue. Br J Cancer 54: 409-414. 989; 108: 2435-2447, 1988.
18. Eckert K, Fuhrmann-Selter T, Büttner P, Maurer HR: A colorimetric immunoassay for the detection of E-cadherin and carcinoembryonic antigen (CEA) on human colon carcinoma cell lines. Cancer Letters 105: 1-4, 1996.
19. Dorudi S, Hanby AM, Poulsom R, Northover J, Hart IR: Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome, Br J of Cancer 71: 614-616, 1995.
20. Vleminckx K, Vakaet L jr., Mareel M, Fiers W, van Roy FM: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119, 1991.
21. Birchmeier W: E-cadherin is a tumor (invasion) suppressor gene. Bioassays 17: 97-99, 1995.
22. Gold P, Freedman SO: Demonstration of tumor specific antigens in human colonic carcinoma by immunological tolerance and absorbance techniques. J Exp Med 121: 439-462, 1965.
23. Blottiere HM, Zennadi R, Gregoire M, Aillet G, Denis MG, Meflah K, Le Pendu J: Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells. Int J Cancer 53: 409-417, 1993.
24. Pignatelli M, Leu D, Naseni MM, Staup GWH, Hirano S, Takeichi M: Morphoregulatory activities of E-cadherin and β1 -integrins in colorectal tumor cells. Br J Cancer 66: 629-634, 1992.
25. Dimanche-Boitrel MT, Vakaet jr. L, Pujuguet P, Chauffert B, Martin MS, Hammann A, Van Roy F, Marcel MM, Martin F: In vivo and in vitro invasivness of a rat colon-cancer cell line maintaining Ecadherin expression: an enhancing role of tumor-associated myofibroblasts. Int J Cancer 56: 512-521, 1994.
26. Vermeulen SJ, Bruyneel EA, Bracke ME, De Bruyne GK, Vennekens KM, Vleminckx KL, Berx GJ, van Roy FM, Mareel MM: Transition from non-invasive to invasive phenotype and loss of a-catenin in human colon cancer cells. Cancer Res 55: 4722-4728, 1995.
27. Jiang WG: E-cadherin and its associated protein catenins, cancer invasion and metastasis. Br J Surgery 83: 437-446, 1996.
28. Leung MF, Sartorelli AC: The effects of microtubule disrupting drugs on the differentiation on HL-60 leukemia cells. Leukemia Res 16: 929-935, 1992.
29. Hunes R, Burton PR, Kersey RN, Pierson GB: Brain tubulin polymerisation in the absence of ''microtubule-associated proteins". Proc Natn Acad Sci USA 73: 4397-4399, 1976.
30. Vermeulen S, Bryneel E, Vanroy F, Bracke M, Mareel MM: Novel function for all-trans-retinoic acid: Induction of adhesive function of E-cadherin in human cancer cells. Cell Biol Int 19: 251, 1995.
31. Ikai K, Yamamoto M, Matsuyoshi N, Fukushima M: Effect of a cytotoxic prostaglandin. Delta (12)-prostaglandin J(2) on E-cadherin expression in transformed epidermal cells in culture. Prostaglandins, Leukotriens and Essential Fatty Acids 52: 303-307, 1995.
32. Friedman J, Seger H, Levinsky H, Allalouf D: Modulation of carcinoembryonic antigen release by HT-29 colon carcinoma line in the presence of different agents. Experientia 43: 1121-1122, 1987.
33. Omary MB, de Grandpre L, McCafrey M, Kagnoff MF: Biochemical and morphological differentiation of the human colonic cell line SW620 in the presence of dimethylsulfoxide. J Cell Bioch 48: 316-323, 1992.
34. Beauchemin N, Benchimol S, Cournoyer D, Fuks A, Stanners CP: Isolation and characterization of full length functional cDNA clones for human carcinoembryonic antigen. Mol Cell Biol 7: 3221-3230, 1987.
35. Chakrabarty S, Fan D, Varani J. Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor β1 and β2. Cancer Res 46: 493-499, 1990.
36. Garbin F, Eckert K, Maurer H. R. Evaluation of the MTT and SRB assays for testing LAK cell-mediated growth inhibition of various adherent and nonadherent tumor target cells. J Immunol Methods 170: 269-271, 1994.